Jiangsu Cnano Technology（688116）株式概要江蘇中能科技有限公司は、中国においてカーボンナノチューブ材料および関連製品の研究、開発、生産、販売を行っている。 詳細688116 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長5/6過去の実績2/6財務の健全性5/6配当金1/6報酬収益は年間44.54%増加すると予測されています アナリストらは、株価が22.3%上昇するだろうとほぼ一致している。 リスク分析リスクチェックの結果、688116 、リスクは検出されなかった。すべてのリスクチェックを見る688116 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCN¥Current PriceCN¥39.2854.4% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture04b2016201920222025202620282031Revenue CN¥4.4bEarnings CN¥784.4mAdvancedSet Fair ValueView all narrativesJiangsu Cnano Technology Co., Ltd. 競合他社Wankai New MaterialsSymbol: SZSE:301216Market cap: CN¥14.2bLuxin Venture Capital GroupSymbol: SHSE:600783Market cap: CN¥17.6bGuizhou RedStar DevelopingLtdSymbol: SHSE:600367Market cap: CN¥16.9bLianhe Chemical TechnologyLtdSymbol: SZSE:002250Market cap: CN¥12.6b価格と性能株価の高値、安値、推移の概要Jiangsu Cnano Technology過去の株価現在の株価CN¥39.2852週高値CN¥69.9952週安値CN¥36.82ベータ0.621ヶ月の変化-9.41%3ヶ月変化-6.48%1年変化-8.37%3年間の変化26.13%5年間の変化-40.28%IPOからの変化13.12%最新ニュースValuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥38.24, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.New Risk • May 12New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Cash payout ratio: 157% Dividend yield: 0.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.Major Estimate Revision • May 06Consensus revenue estimates fall by 34%The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from CN¥2.52b to CN¥1.67b. EPS estimate fell from CN¥1.58 to CN¥1.18 per share. Net income forecast to grow 123% next year vs 57% growth forecast for Chemicals industry in China. Consensus price target of CN¥51.02 unchanged from last update. Share price was steady at CN¥43.36 over the past week.Reported Earnings • Apr 30Full year 2025 earnings released: EPS: CN¥0.63 (vs CN¥0.73 in FY 2024)Full year 2025 results: EPS: CN¥0.63 (down from CN¥0.73 in FY 2024). Revenue: CN¥1.30b (down 10% from FY 2024). Net income: CN¥227.8m (down 8.9% from FY 2024). Profit margin: 18% (in line with FY 2024). Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.お知らせ • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026, at 09:00 China Standard Time. Location: No. 520, Changshun Road, Wujin District, Changzhou, Jiangsu Chinaお知らせ • Mar 30Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥38.24, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.New Risk • May 12New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Cash payout ratio: 157% Dividend yield: 0.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.Major Estimate Revision • May 06Consensus revenue estimates fall by 34%The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from CN¥2.52b to CN¥1.67b. EPS estimate fell from CN¥1.58 to CN¥1.18 per share. Net income forecast to grow 123% next year vs 57% growth forecast for Chemicals industry in China. Consensus price target of CN¥51.02 unchanged from last update. Share price was steady at CN¥43.36 over the past week.Reported Earnings • Apr 30Full year 2025 earnings released: EPS: CN¥0.63 (vs CN¥0.73 in FY 2024)Full year 2025 results: EPS: CN¥0.63 (down from CN¥0.73 in FY 2024). Revenue: CN¥1.30b (down 10% from FY 2024). Net income: CN¥227.8m (down 8.9% from FY 2024). Profit margin: 18% (in line with FY 2024). Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.お知らせ • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026, at 09:00 China Standard Time. Location: No. 520, Changshun Road, Wujin District, Changzhou, Jiangsu Chinaお知らせ • Mar 30Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026Reported Earnings • Mar 05Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: CN¥0.66 (down from CN¥0.73 in FY 2024). Revenue: CN¥1.30b (down 10% from FY 2024). Net income: CN¥235.8m (down 5.7% from FY 2024). Profit margin: 18% (in line with FY 2024). Revenue missed analyst estimates by 23%. Earnings per share (EPS) also missed analyst estimates by 25%. Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Mar 03Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥41.00, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 10% over the past three years.お知らせ • Dec 26Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026Valuation Update With 7 Day Price Move • Nov 24Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥48.62, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 24% over the past three years.Major Estimate Revision • Nov 02Consensus revenue estimates fall by 24%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥1.95b to CN¥1.47b. EPS estimate fell from CN¥1.06 to CN¥0.825 per share. Net income forecast to grow 90% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target up from CN¥50.57 to CN¥54.85. Share price was steady at CN¥57.49 over the past week.Price Target Changed • Oct 31Price target increased by 8.5% to CN¥54.85Up from CN¥50.57, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CN¥57.49. Stock is up 102% over the past year. The company is forecast to post earnings per share of CN¥0.82 for next year compared to CN¥0.73 last year.Reported Earnings • Oct 27Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.22 (up from CN¥0.19 in 3Q 2024). Revenue: CN¥347.3m (down 12% from 3Q 2024). Net income: CN¥79.4m (up 18% from 3Q 2024). Profit margin: 23% (up from 17% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 42%. Earnings per share (EPS) also missed analyst estimates by 51%. Revenue is forecast to grow 35% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025New Risk • Sep 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Major Estimate Revision • Sep 05Consensus EPS estimates fall by 16%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥2.12b to CN¥1.93b. EPS estimate also fell from CN¥1.19 per share to CN¥0.998 per share. Net income forecast to grow 84% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥44.79 to CN¥50.57. Share price rose 7.3% to CN¥54.95 over the past week.Price Target Changed • Sep 02Price target increased by 11% to CN¥49.54Up from CN¥44.79, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of CN¥50.95. Stock is up 144% over the past year. The company is forecast to post earnings per share of CN¥1.17 for next year compared to CN¥0.73 last year.Reported Earnings • Aug 31Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: CN¥0.16 (down from CN¥0.18 in 2Q 2024). Revenue: CN¥318.9m (down 6.1% from 2Q 2024). Net income: CN¥58.6m (down 5.1% from 2Q 2024). Profit margin: 18% (in line with 2Q 2024). Revenue missed analyst estimates by 12%. Earnings per share (EPS) also missed analyst estimates by 46%. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year whereas the company’s share price has fallen by 14% per year.お知らせ • Jun 30Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025Declared Dividend • Jun 25Dividend reduced to CN¥0.15Dividend of CN¥0.15 is 51% lower than last year. Ex-date: 30th June 2025 Payment date: 30th June 2025 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (20% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.6% per year over the past 5 years. However, payments have been volatile during that time. EPS is expected to grow by 160% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Apr 30Full year 2024 earnings released: EPS: CN¥0.73 (vs CN¥0.87 in FY 2023)Full year 2024 results: EPS: CN¥0.73 (down from CN¥0.87 in FY 2023). Revenue: CN¥1.45b (up 3.1% from FY 2023). Net income: CN¥250.2m (down 16% from FY 2023). Profit margin: 17% (down from 21% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings.お知らせ • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025, at 09:00 China Standard Time. Location: No. 113, Qinglongshan Road, New District, Zhenjiang, Jiangsu ChinaNew Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.7% average weekly change).Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥35.08, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years.お知らせ • Mar 28Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025分析記事 • Mar 10Downgrade: Here's How Analysts See Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) Performing In The Near TermMarket forces rained on the parade of Jiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders today, when the...Major Estimate Revision • Mar 10Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥2.79b to CN¥2.47b. EPS estimate fell from CN¥1.63 to CN¥1.24 per share. Net income forecast to grow 61% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target up from CN¥29.63 to CN¥35.80. Share price fell 2.9% to CN¥47.62 over the past week.分析記事 • Mar 06Why Investors Shouldn't Be Surprised By Jiangsu Cnano Technology Co., Ltd.'s (SHSE:688116) 26% Share Price SurgeJiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders would be excited to see that the share price has had a...Reported Earnings • Mar 02Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2024 results: EPS: CN¥0.74 (down from CN¥0.87 in FY 2023). Revenue: CN¥1.45b (up 3.2% from FY 2023). Net income: CN¥253.3m (down 15% from FY 2023). Profit margin: 18% (down from 21% in FY 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 13%. Earnings per share (EPS) exceeded analyst estimates by 6.6%. Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings.Valuation Update With 7 Day Price Move • Feb 25Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥48.29, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 52% over the past three years.分析記事 • Feb 05Is Jiangsu Cnano Technology (SHSE:688116) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...お知らせ • Jan 11Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces an Equity Buyback for CNY 100 million worth of its shares.Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 63.47 per share. The shares purchased will be used for the company's equity incentive plans and/or employee stock ownership plans. The program will be funded out of the company's own funds. The program will be valid till 12 months.お知らせ • Dec 27Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 30, 2025分析記事 • Nov 21At CN¥45.79, Is It Time To Put Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) On Your Watch List?Jiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ), is not the largest company out there, but it saw a significant...New Risk • Nov 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Paying a dividend despite having no free cash flows.Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improves as stock rises 34%After last week's 34% share price gain to CN¥38.47, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years.Major Estimate Revision • Nov 01Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥0.85 to CN¥0.752 per share. Revenue forecast steady at CN¥1.58b. Net income forecast to grow 31% next year vs 57% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.18 to CN¥31.23. Share price fell 6.4% to CN¥28.45 over the past week.Price Target Changed • Oct 29Price target increased by 19% to CN¥29.97Up from CN¥25.18, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥28.80. Stock is down 1.4% over the past year. The company is forecast to post earnings per share of CN¥0.78 for next year compared to CN¥0.87 last year.Reported Earnings • Oct 26Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: CN¥0.19 (down from CN¥0.21 in 3Q 2023). Revenue: CN¥393.7m (down 5.6% from 3Q 2023). Net income: CN¥67.1m (down 6.3% from 3Q 2023). Profit margin: 17% (in line with 3Q 2023). Revenue missed analyst estimates by 22%. Earnings per share (EPS) also missed analyst estimates by 29%. Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 35% per year, which means it is performing significantly worse than earnings.分析記事 • Oct 18Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) Stock Rockets 36% But Many Are Still Ignoring The CompanyJiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders would be excited to see that the share price has had a...Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to CN¥25.10, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 75% over the past three years.New Risk • Sep 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.7% average weekly change).お知らせ • Sep 30Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 25%After last week's 25% share price gain to CN¥24.48, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 75% over the past three years.分析記事 • Sep 24Jiangsu Cnano Technology (SHSE:688116) Might Be Having Difficulty Using Its Capital EffectivelyWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...分析記事 • Sep 01Fewer Investors Than Expected Jumping On Jiangsu Cnano Technology Co., Ltd. (SHSE:688116)Jiangsu Cnano Technology Co., Ltd.'s ( SHSE:688116 ) price-to-earnings (or "P/E") ratio of 21.3x might make it look...Reported Earnings • Aug 31Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥339.5m (down 6.3% from 2Q 2023). Net income: CN¥61.7m (up 23% from 2Q 2023). Profit margin: 18% (up from 14% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 4.7%. Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.分析記事 • Aug 13News Flash: 4 Analysts Think Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) Earnings Are Under ThreatToday is shaping up negative for Jiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders, with the analysts...Major Estimate Revision • Aug 13Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.98b to CN¥1.71b. EPS estimate fell from CN¥1.12 to CN¥0.913 per share. Net income forecast to grow 14% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥30.53 to CN¥28.03. Share price fell 3.3% to CN¥20.27 over the past week.分析記事 • Jun 28Jiangsu Cnano Technology (SHSE:688116) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...お知らせ • Jun 28Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024分析記事 • Jun 10Jiangsu Cnano Technology (SHSE:688116) Will Want To Turn Around Its Return TrendsIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...分析記事 • May 03Jiangsu Cnano Technology's (SHSE:688116) Anemic Earnings Might Be Worse Than You ThinkJiangsu Cnano Technology Co., Ltd.'s ( SHSE:688116 ) stock showed strength, with investors undeterred by its weak...Major Estimate Revision • May 03Consensus revenue estimates increase by 24%, EPS downgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from CN¥1.71b to CN¥2.13b. EPS estimate fell from CN¥1.35 to CN¥1.20. Net income forecast to grow 49% next year vs 57% growth forecast for Chemicals industry in China. Consensus price target up from CN¥31.57 to CN¥32.40. Share price rose 8.3% to CN¥29.36 over the past week.分析記事 • Apr 29Jiangsu Cnano Technology Co., Ltd.'s (SHSE:688116) Shares Leap 25% Yet They're Still Not Telling The Full StoryJiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shares have continued their recent momentum with a 25% gain in the...お知らせ • Apr 29Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024, at 09:00 China Standard Time. Location: The Company's Meeting Room, Zhenjiang, Jiangsu ChinaReported Earnings • Apr 27Full year 2023 earnings: Revenues miss analyst expectationsFull year 2023 results: Revenue: CN¥1.40b (down 24% from FY 2022). Net income: CN¥297.2m (down 30% from FY 2022). Profit margin: 21% (down from 23% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 23%. Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.分析記事 • Apr 16Is Now The Time To Look At Buying Jiangsu Cnano Technology Co., Ltd. (SHSE:688116)?Jiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ), might not be a large cap stock, but it saw a significant share...Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥28.83, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 26% over the past three years.お知らせ • Mar 29Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024分析記事 • Mar 04Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) Stock Rockets 26% But Many Are Still Ignoring The CompanyJiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders are no doubt pleased to see that the share price has...分析記事 • Feb 28Jiangsu Cnano Technology (SHSE:688116) Has A Somewhat Strained Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to CN¥15.75, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 66% over the past three years.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥22.20, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years.New Risk • Jan 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.9% average weekly change). High level of non-cash earnings (26% accrual ratio).Reported Earnings • Nov 01Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.36 in 3Q 2022). Revenue: CN¥417.3m (down 17% from 3Q 2022). Net income: CN¥71.6m (down 42% from 3Q 2022). Profit margin: 17% (down from 25% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 45%. Earnings per share (EPS) also missed analyst estimates by 58%. Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥29.44, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 1.7% over the past three years.Price Target Changed • Sep 01Price target decreased by 15% to CN¥32.88Down from CN¥38.88, the current price target is an average from 4 analysts. New target price is 24% above last closing price of CN¥26.48. Stock is down 67% over the past year. The company is forecast to post earnings per share of CN¥1.10 for next year compared to CN¥1.24 last year.Reported Earnings • Aug 30Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.30 in 2Q 2022). Revenue: CN¥362.3m (down 21% from 2Q 2022). Net income: CN¥50.1m (down 52% from 2Q 2022). Profit margin: 14% (down from 23% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 75%. Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Major Estimate Revision • Aug 30Consensus revenue estimates fall by 21%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥2.44b to CN¥1.91b. EPS estimate fell from CN¥1.35 to CN¥1.04 per share. Net income forecast to grow 21% next year vs 63% growth forecast for Chemicals industry in China. Consensus price target down from CN¥38.88 to CN¥37.63. Share price rose 2.1% to CN¥26.88 over the past week.Price Target Changed • Jul 29Price target increased by 7.6% to CN¥38.88Up from CN¥36.12, the current price target is an average from 4 analysts. New target price is 37% above last closing price of CN¥28.29. Stock is down 72% over the past year. The company is forecast to post earnings per share of CN¥1.35 for next year compared to CN¥1.24 last year.Valuation Update With 7 Day Price Move • Jul 06Investor sentiment deteriorates as stock falls 30%After last week's 30% share price decline to CN¥30.05, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years.お知らせ • Jun 28Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change).Major Estimate Revision • Jun 08Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥2.55b to CN¥2.44b. EPS estimate also fell from CN¥2.26 per share to CN¥2.00 per share. Net income forecast to grow 44% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥69.96 to CN¥57.46. Share price fell 7.5% to CN¥42.82 over the past week.Major Estimate Revision • Apr 28Consensus revenue estimates decrease by 19%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥3.40b to CN¥2.77b. EPS estimate unchanged from CN¥3.26 per share at last update. Chemicals industry in China expected to see average net income growth of 46% next year. Consensus price target of CN¥97.28 unchanged from last update. Share price was steady at CN¥53.88 over the past week.Reported Earnings • Apr 21First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.43 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.43 in 1Q 2022). Revenue: CN¥278.7m (down 42% from 1Q 2022). Net income: CN¥39.7m (down 60% from 1Q 2022). Profit margin: 14% (down from 21% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 56% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Apr 20Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥56.79, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 47% over the past three years.Major Estimate Revision • Apr 04Consensus revenue estimates increase by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from CN¥2.86b to CN¥3.18b. EPS estimate unchanged from CN¥3.41 at last update. Chemicals industry in China expected to see average net income growth of 38% next year. Consensus price target of CN¥97.28 unchanged from last update. Share price fell 5.3% to CN¥64.70 over the past week.Reported Earnings • Feb 25Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥1.77 (up from CN¥1.28 in FY 2021). Revenue: CN¥1.84b (up 39% from FY 2021). Net income: CN¥411.0m (up 39% from FY 2021). Profit margin: 22% (in line with FY 2021). Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.お知らせ • Dec 28Jiangsu Cnano Technology Co., Ltd. announced that it expects to receive CNY 2 billion in fundingJiangsu Cnano Technology Co., Ltd. announced a private placement of not exceeding 69,756,317 shares at an issue price for a gross proceeds of not exceeding CNY 2,000,000,000 on December 27, 2022. The issue price of issuance shall not be lower than 80% of the average trading price of the company's stock in the 20 trading days prior to the pricing base date. The transaction will include participation from not more than 35 specific investors. The transaction has been approved at the second board of directors of the company. The transaction is still subject to the company's general meeting of shareholders, Shanghai Stock Exchange and China Securities Regulatory Commission.お知らせ • Dec 15Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces an Equity Buyback for CNY 200 million worth of its shares.Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 140 per share. The shares purchased will be used for the company's equity incentive plans and/or employee stock ownership plans. The program will be funded out of the company's own funds. The program will be valid till 12 months.Valuation Update With 7 Day Price Move • Dec 13Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥83.82, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 185% over the past three years.Price Target Changed • Nov 16Price target decreased to CN¥137Down from CN¥155, the current price target is an average from 2 analysts. New target price is 39% above last closing price of CN¥98.65. Stock is down 36% over the past year. The company is forecast to post earnings per share of CN¥2.19 for next year compared to CN¥1.28 last year.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Xinxin Wang was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥110, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 295% over the past three years.Price Target Changed • Oct 28Price target decreased to CN¥137Down from CN¥155, the current price target is an average from 2 analysts. New target price is 47% above last closing price of CN¥93.30. Stock is down 42% over the past year. The company is forecast to post earnings per share of CN¥2.19 for next year compared to CN¥1.28 last year.Reported Earnings • Oct 25Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.36 in 3Q 2021). Revenue: CN¥501.1m (up 29% from 3Q 2021). Net income: CN¥123.7m (up 49% from 3Q 2021). Profit margin: 25% (up from 21% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 21%. Earnings per share (EPS) also missed analyst estimates by 39%. Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year whereas the company’s share price has increased by 49% per year.Major Estimate Revision • Aug 31Consensus revenue estimates fall by 14%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥2.93b to CN¥2.51b. EPS estimate fell from CN¥2.68 to CN¥2.25 per share. Net income forecast to grow 126% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target of CN¥162 unchanged from last update. Share price fell 13% to CN¥121 over the past week.Reported Earnings • Aug 26Second quarter 2022 earnings: EPS and revenues miss analyst expectationsSecond quarter 2022 results: EPS: CN¥0.45 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥460.8m (up 52% from 2Q 2021). Net income: CN¥104.2m (up 55% from 2Q 2021). Profit margin: 23% (in line with 2Q 2021). Revenue missed analyst estimates by 4.3%. Earnings per share (EPS) also missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 85%, compared to a 42% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 30First quarter 2022 earnings: EPS misses analyst expectationsFirst quarter 2022 results: EPS: CN¥0.43 (up from CN¥0.23 in 1Q 2021). Revenue: CN¥480.5m (up 120% from 1Q 2021). Net income: CN¥100.0m (up 88% from 1Q 2021). Profit margin: 21% (down from 24% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 19%. Over the next year, revenue is forecast to grow 87%, compared to a 43% growth forecast for the industry in China.Price Target Changed • Apr 27Price target increased to CN¥170Up from CN¥89.90, the current price target is an average from 3 analysts. New target price is 47% above last closing price of CN¥115. Stock is up 75% over the past year. The company is forecast to post earnings per share of CN¥2.66 for next year compared to CN¥1.28 last year.Board Change • Apr 27No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Ge Yan was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Apr 20Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥1.28 (up from CN¥0.46 in FY 2020). Revenue: CN¥1.32b (up 180% from FY 2020). Net income: CN¥295.9m (up 176% from FY 2020). Profit margin: 22% (in line with FY 2020). Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) were mostly in line with analyst estimates. Over the next year, revenue is forecast to grow 102%, compared to a 48% growth forecast for the industry in China.Reported Earnings • Feb 28Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥1.29 (up from CN¥0.46 in FY 2020). Revenue: CN¥1.36b (up 189% from FY 2020). Net income: CN¥298.8m (up 179% from FY 2020). Profit margin: 22% (in line with FY 2020). Revenue exceeded analyst estimates by 5.5%. Earnings per share (EPS) were mostly in line with analyst estimates. Over the next year, revenue is forecast to grow 91%, compared to a 47% growth forecast for the industry in China.Reported Earnings • Aug 26Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.078 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥304.0m (up 202% from 2Q 2020). Net income: CN¥67.2m (up 237% from 2Q 2020). Profit margin: 22% (up from 20% in 2Q 2020). The increase in margin was driven by higher revenue.Reported Earnings • Apr 30First quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.06 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥218.6m (up 262% from 1Q 2020). Net income: CN¥53.3m (up 315% from 1Q 2020). Profit margin: 24% (up from 21% in 1Q 2020). The increase in margin was driven by higher revenue.Reported Earnings • Apr 01Full year 2020 earnings released: EPS CN¥0.46 (vs CN¥0.58 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥471.9m (up 22% from FY 2019). Net income: CN¥107.3m (down 2.6% from FY 2019). Profit margin: 23% (down from 28% in FY 2019). The decrease in margin was driven by higher expenses.株主還元688116CN ChemicalsCN 市場7D-9.8%-2.9%-1.8%1Y-8.4%54.3%30.2%株主還元を見る業界別リターン: 688116過去 1 年間で54.3 % の収益を上げたCN Chemicals業界を下回りました。リターン対市場: 688116は、過去 1 年間で30.2 % のリターンを上げたCN市場を下回りました。価格変動Is 688116's price volatile compared to industry and market?688116 volatility688116 Average Weekly Movement5.7%Chemicals Industry Average Movement6.9%Market Average Movement6.5%10% most volatile stocks in CN Market10.2%10% least volatile stocks in CN Market4.2%安定した株価: 688116 、 CN市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 688116の 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2011843Tao Zhengwww.cnanotechnology.com/江蘇中能科技有限公司は中国でカーボンナノチューブ材料と関連製品の研究、開発、生産、販売を行っている。同社の製品には、カーボンナノチューブ粉末、カーボンナノチューブおよびグラフェン導電ペースト、カーボンナノチューブ導電マスターバッチなどがある。同社の製品は、リチウム電池、スーパーキャパシタ、鉛蓄電池、導電性高分子複合材料、帯電防止コーティング、スポーツ用品、タイヤゴム補強などに使用されている。同社は2011年に設立され、中国の鎮江に本社を置いている。もっと見るJiangsu Cnano Technology Co., Ltd. 基礎のまとめJiangsu Cnano Technology の収益と売上を時価総額と比較するとどうか。688116 基礎統計学時価総額CN¥14.40b収益（TTM）CN¥226.05m売上高(TTM)CN¥1.28b63.7xPER（株価収益率11.3xP/Sレシオ688116 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計688116 損益計算書（TTM）収益CN¥1.28b売上原価CN¥799.17m売上総利益CN¥478.72mその他の費用CN¥252.67m収益CN¥226.05m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.62グロス・マージン37.46%純利益率17.69%有利子負債／自己資本比率38.1%688116 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.4%現在の配当利回り19%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/05 23:19終値2026/06/05 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Jiangsu Cnano Technology Co., Ltd. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Han YuChina International Capital Corporation LimitedWeichen WuCitic Securities Co., Ltd.Weiqi WangGuosen Securities Co., Ltd.4 その他のアナリストを表示
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥38.24, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.
New Risk • May 12New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Cash payout ratio: 157% Dividend yield: 0.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
Major Estimate Revision • May 06Consensus revenue estimates fall by 34%The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from CN¥2.52b to CN¥1.67b. EPS estimate fell from CN¥1.58 to CN¥1.18 per share. Net income forecast to grow 123% next year vs 57% growth forecast for Chemicals industry in China. Consensus price target of CN¥51.02 unchanged from last update. Share price was steady at CN¥43.36 over the past week.
Reported Earnings • Apr 30Full year 2025 earnings released: EPS: CN¥0.63 (vs CN¥0.73 in FY 2024)Full year 2025 results: EPS: CN¥0.63 (down from CN¥0.73 in FY 2024). Revenue: CN¥1.30b (down 10% from FY 2024). Net income: CN¥227.8m (down 8.9% from FY 2024). Profit margin: 18% (in line with FY 2024). Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
お知らせ • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026, at 09:00 China Standard Time. Location: No. 520, Changshun Road, Wujin District, Changzhou, Jiangsu China
お知らせ • Mar 30Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥38.24, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.
New Risk • May 12New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Cash payout ratio: 157% Dividend yield: 0.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
Major Estimate Revision • May 06Consensus revenue estimates fall by 34%The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from CN¥2.52b to CN¥1.67b. EPS estimate fell from CN¥1.58 to CN¥1.18 per share. Net income forecast to grow 123% next year vs 57% growth forecast for Chemicals industry in China. Consensus price target of CN¥51.02 unchanged from last update. Share price was steady at CN¥43.36 over the past week.
Reported Earnings • Apr 30Full year 2025 earnings released: EPS: CN¥0.63 (vs CN¥0.73 in FY 2024)Full year 2025 results: EPS: CN¥0.63 (down from CN¥0.73 in FY 2024). Revenue: CN¥1.30b (down 10% from FY 2024). Net income: CN¥227.8m (down 8.9% from FY 2024). Profit margin: 18% (in line with FY 2024). Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
お知らせ • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026, at 09:00 China Standard Time. Location: No. 520, Changshun Road, Wujin District, Changzhou, Jiangsu China
お知らせ • Mar 30Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
Reported Earnings • Mar 05Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: CN¥0.66 (down from CN¥0.73 in FY 2024). Revenue: CN¥1.30b (down 10% from FY 2024). Net income: CN¥235.8m (down 5.7% from FY 2024). Profit margin: 18% (in line with FY 2024). Revenue missed analyst estimates by 23%. Earnings per share (EPS) also missed analyst estimates by 25%. Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Mar 03Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥41.00, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 10% over the past three years.
お知らせ • Dec 26Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026
Valuation Update With 7 Day Price Move • Nov 24Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥48.62, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 24% over the past three years.
Major Estimate Revision • Nov 02Consensus revenue estimates fall by 24%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥1.95b to CN¥1.47b. EPS estimate fell from CN¥1.06 to CN¥0.825 per share. Net income forecast to grow 90% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target up from CN¥50.57 to CN¥54.85. Share price was steady at CN¥57.49 over the past week.
Price Target Changed • Oct 31Price target increased by 8.5% to CN¥54.85Up from CN¥50.57, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CN¥57.49. Stock is up 102% over the past year. The company is forecast to post earnings per share of CN¥0.82 for next year compared to CN¥0.73 last year.
Reported Earnings • Oct 27Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.22 (up from CN¥0.19 in 3Q 2024). Revenue: CN¥347.3m (down 12% from 3Q 2024). Net income: CN¥79.4m (up 18% from 3Q 2024). Profit margin: 23% (up from 17% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 42%. Earnings per share (EPS) also missed analyst estimates by 51%. Revenue is forecast to grow 35% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025
New Risk • Sep 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Major Estimate Revision • Sep 05Consensus EPS estimates fall by 16%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥2.12b to CN¥1.93b. EPS estimate also fell from CN¥1.19 per share to CN¥0.998 per share. Net income forecast to grow 84% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥44.79 to CN¥50.57. Share price rose 7.3% to CN¥54.95 over the past week.
Price Target Changed • Sep 02Price target increased by 11% to CN¥49.54Up from CN¥44.79, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of CN¥50.95. Stock is up 144% over the past year. The company is forecast to post earnings per share of CN¥1.17 for next year compared to CN¥0.73 last year.
Reported Earnings • Aug 31Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: CN¥0.16 (down from CN¥0.18 in 2Q 2024). Revenue: CN¥318.9m (down 6.1% from 2Q 2024). Net income: CN¥58.6m (down 5.1% from 2Q 2024). Profit margin: 18% (in line with 2Q 2024). Revenue missed analyst estimates by 12%. Earnings per share (EPS) also missed analyst estimates by 46%. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year whereas the company’s share price has fallen by 14% per year.
お知らせ • Jun 30Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025
Declared Dividend • Jun 25Dividend reduced to CN¥0.15Dividend of CN¥0.15 is 51% lower than last year. Ex-date: 30th June 2025 Payment date: 30th June 2025 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (20% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.6% per year over the past 5 years. However, payments have been volatile during that time. EPS is expected to grow by 160% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Apr 30Full year 2024 earnings released: EPS: CN¥0.73 (vs CN¥0.87 in FY 2023)Full year 2024 results: EPS: CN¥0.73 (down from CN¥0.87 in FY 2023). Revenue: CN¥1.45b (up 3.1% from FY 2023). Net income: CN¥250.2m (down 16% from FY 2023). Profit margin: 17% (down from 21% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings.
お知らせ • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025, at 09:00 China Standard Time. Location: No. 113, Qinglongshan Road, New District, Zhenjiang, Jiangsu China
New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.7% average weekly change).
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥35.08, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years.
お知らせ • Mar 28Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025
分析記事 • Mar 10Downgrade: Here's How Analysts See Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) Performing In The Near TermMarket forces rained on the parade of Jiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders today, when the...
Major Estimate Revision • Mar 10Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥2.79b to CN¥2.47b. EPS estimate fell from CN¥1.63 to CN¥1.24 per share. Net income forecast to grow 61% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target up from CN¥29.63 to CN¥35.80. Share price fell 2.9% to CN¥47.62 over the past week.
分析記事 • Mar 06Why Investors Shouldn't Be Surprised By Jiangsu Cnano Technology Co., Ltd.'s (SHSE:688116) 26% Share Price SurgeJiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders would be excited to see that the share price has had a...
Reported Earnings • Mar 02Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2024 results: EPS: CN¥0.74 (down from CN¥0.87 in FY 2023). Revenue: CN¥1.45b (up 3.2% from FY 2023). Net income: CN¥253.3m (down 15% from FY 2023). Profit margin: 18% (down from 21% in FY 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 13%. Earnings per share (EPS) exceeded analyst estimates by 6.6%. Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings.
Valuation Update With 7 Day Price Move • Feb 25Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥48.29, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 52% over the past three years.
分析記事 • Feb 05Is Jiangsu Cnano Technology (SHSE:688116) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
お知らせ • Jan 11Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces an Equity Buyback for CNY 100 million worth of its shares.Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 63.47 per share. The shares purchased will be used for the company's equity incentive plans and/or employee stock ownership plans. The program will be funded out of the company's own funds. The program will be valid till 12 months.
お知らせ • Dec 27Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 30, 2025
分析記事 • Nov 21At CN¥45.79, Is It Time To Put Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) On Your Watch List?Jiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ), is not the largest company out there, but it saw a significant...
New Risk • Nov 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Paying a dividend despite having no free cash flows.
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improves as stock rises 34%After last week's 34% share price gain to CN¥38.47, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years.
Major Estimate Revision • Nov 01Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥0.85 to CN¥0.752 per share. Revenue forecast steady at CN¥1.58b. Net income forecast to grow 31% next year vs 57% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.18 to CN¥31.23. Share price fell 6.4% to CN¥28.45 over the past week.
Price Target Changed • Oct 29Price target increased by 19% to CN¥29.97Up from CN¥25.18, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥28.80. Stock is down 1.4% over the past year. The company is forecast to post earnings per share of CN¥0.78 for next year compared to CN¥0.87 last year.
Reported Earnings • Oct 26Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: CN¥0.19 (down from CN¥0.21 in 3Q 2023). Revenue: CN¥393.7m (down 5.6% from 3Q 2023). Net income: CN¥67.1m (down 6.3% from 3Q 2023). Profit margin: 17% (in line with 3Q 2023). Revenue missed analyst estimates by 22%. Earnings per share (EPS) also missed analyst estimates by 29%. Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 35% per year, which means it is performing significantly worse than earnings.
分析記事 • Oct 18Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) Stock Rockets 36% But Many Are Still Ignoring The CompanyJiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders would be excited to see that the share price has had a...
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to CN¥25.10, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 75% over the past three years.
New Risk • Sep 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.7% average weekly change).
お知らせ • Sep 30Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 25%After last week's 25% share price gain to CN¥24.48, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 75% over the past three years.
分析記事 • Sep 24Jiangsu Cnano Technology (SHSE:688116) Might Be Having Difficulty Using Its Capital EffectivelyWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
分析記事 • Sep 01Fewer Investors Than Expected Jumping On Jiangsu Cnano Technology Co., Ltd. (SHSE:688116)Jiangsu Cnano Technology Co., Ltd.'s ( SHSE:688116 ) price-to-earnings (or "P/E") ratio of 21.3x might make it look...
Reported Earnings • Aug 31Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥339.5m (down 6.3% from 2Q 2023). Net income: CN¥61.7m (up 23% from 2Q 2023). Profit margin: 18% (up from 14% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 4.7%. Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
分析記事 • Aug 13News Flash: 4 Analysts Think Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) Earnings Are Under ThreatToday is shaping up negative for Jiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders, with the analysts...
Major Estimate Revision • Aug 13Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.98b to CN¥1.71b. EPS estimate fell from CN¥1.12 to CN¥0.913 per share. Net income forecast to grow 14% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥30.53 to CN¥28.03. Share price fell 3.3% to CN¥20.27 over the past week.
分析記事 • Jun 28Jiangsu Cnano Technology (SHSE:688116) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
お知らせ • Jun 28Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024
分析記事 • Jun 10Jiangsu Cnano Technology (SHSE:688116) Will Want To Turn Around Its Return TrendsIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
分析記事 • May 03Jiangsu Cnano Technology's (SHSE:688116) Anemic Earnings Might Be Worse Than You ThinkJiangsu Cnano Technology Co., Ltd.'s ( SHSE:688116 ) stock showed strength, with investors undeterred by its weak...
Major Estimate Revision • May 03Consensus revenue estimates increase by 24%, EPS downgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from CN¥1.71b to CN¥2.13b. EPS estimate fell from CN¥1.35 to CN¥1.20. Net income forecast to grow 49% next year vs 57% growth forecast for Chemicals industry in China. Consensus price target up from CN¥31.57 to CN¥32.40. Share price rose 8.3% to CN¥29.36 over the past week.
分析記事 • Apr 29Jiangsu Cnano Technology Co., Ltd.'s (SHSE:688116) Shares Leap 25% Yet They're Still Not Telling The Full StoryJiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shares have continued their recent momentum with a 25% gain in the...
お知らせ • Apr 29Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024, at 09:00 China Standard Time. Location: The Company's Meeting Room, Zhenjiang, Jiangsu China
Reported Earnings • Apr 27Full year 2023 earnings: Revenues miss analyst expectationsFull year 2023 results: Revenue: CN¥1.40b (down 24% from FY 2022). Net income: CN¥297.2m (down 30% from FY 2022). Profit margin: 21% (down from 23% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 23%. Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.
分析記事 • Apr 16Is Now The Time To Look At Buying Jiangsu Cnano Technology Co., Ltd. (SHSE:688116)?Jiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ), might not be a large cap stock, but it saw a significant share...
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥28.83, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 26% over the past three years.
お知らせ • Mar 29Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024
分析記事 • Mar 04Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) Stock Rockets 26% But Many Are Still Ignoring The CompanyJiangsu Cnano Technology Co., Ltd. ( SHSE:688116 ) shareholders are no doubt pleased to see that the share price has...
分析記事 • Feb 28Jiangsu Cnano Technology (SHSE:688116) Has A Somewhat Strained Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to CN¥15.75, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 66% over the past three years.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥22.20, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years.
New Risk • Jan 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.9% average weekly change). High level of non-cash earnings (26% accrual ratio).
Reported Earnings • Nov 01Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.36 in 3Q 2022). Revenue: CN¥417.3m (down 17% from 3Q 2022). Net income: CN¥71.6m (down 42% from 3Q 2022). Profit margin: 17% (down from 25% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 45%. Earnings per share (EPS) also missed analyst estimates by 58%. Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).
Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥29.44, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 1.7% over the past three years.
Price Target Changed • Sep 01Price target decreased by 15% to CN¥32.88Down from CN¥38.88, the current price target is an average from 4 analysts. New target price is 24% above last closing price of CN¥26.48. Stock is down 67% over the past year. The company is forecast to post earnings per share of CN¥1.10 for next year compared to CN¥1.24 last year.
Reported Earnings • Aug 30Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.30 in 2Q 2022). Revenue: CN¥362.3m (down 21% from 2Q 2022). Net income: CN¥50.1m (down 52% from 2Q 2022). Profit margin: 14% (down from 23% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 75%. Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Aug 30Consensus revenue estimates fall by 21%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥2.44b to CN¥1.91b. EPS estimate fell from CN¥1.35 to CN¥1.04 per share. Net income forecast to grow 21% next year vs 63% growth forecast for Chemicals industry in China. Consensus price target down from CN¥38.88 to CN¥37.63. Share price rose 2.1% to CN¥26.88 over the past week.
Price Target Changed • Jul 29Price target increased by 7.6% to CN¥38.88Up from CN¥36.12, the current price target is an average from 4 analysts. New target price is 37% above last closing price of CN¥28.29. Stock is down 72% over the past year. The company is forecast to post earnings per share of CN¥1.35 for next year compared to CN¥1.24 last year.
Valuation Update With 7 Day Price Move • Jul 06Investor sentiment deteriorates as stock falls 30%After last week's 30% share price decline to CN¥30.05, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years.
お知らせ • Jun 28Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023
New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change).
Major Estimate Revision • Jun 08Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥2.55b to CN¥2.44b. EPS estimate also fell from CN¥2.26 per share to CN¥2.00 per share. Net income forecast to grow 44% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥69.96 to CN¥57.46. Share price fell 7.5% to CN¥42.82 over the past week.
Major Estimate Revision • Apr 28Consensus revenue estimates decrease by 19%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥3.40b to CN¥2.77b. EPS estimate unchanged from CN¥3.26 per share at last update. Chemicals industry in China expected to see average net income growth of 46% next year. Consensus price target of CN¥97.28 unchanged from last update. Share price was steady at CN¥53.88 over the past week.
Reported Earnings • Apr 21First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.43 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.43 in 1Q 2022). Revenue: CN¥278.7m (down 42% from 1Q 2022). Net income: CN¥39.7m (down 60% from 1Q 2022). Profit margin: 14% (down from 21% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 56% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Apr 20Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥56.79, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 47% over the past three years.
Major Estimate Revision • Apr 04Consensus revenue estimates increase by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from CN¥2.86b to CN¥3.18b. EPS estimate unchanged from CN¥3.41 at last update. Chemicals industry in China expected to see average net income growth of 38% next year. Consensus price target of CN¥97.28 unchanged from last update. Share price fell 5.3% to CN¥64.70 over the past week.
Reported Earnings • Feb 25Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥1.77 (up from CN¥1.28 in FY 2021). Revenue: CN¥1.84b (up 39% from FY 2021). Net income: CN¥411.0m (up 39% from FY 2021). Profit margin: 22% (in line with FY 2021). Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
お知らせ • Dec 28Jiangsu Cnano Technology Co., Ltd. announced that it expects to receive CNY 2 billion in fundingJiangsu Cnano Technology Co., Ltd. announced a private placement of not exceeding 69,756,317 shares at an issue price for a gross proceeds of not exceeding CNY 2,000,000,000 on December 27, 2022. The issue price of issuance shall not be lower than 80% of the average trading price of the company's stock in the 20 trading days prior to the pricing base date. The transaction will include participation from not more than 35 specific investors. The transaction has been approved at the second board of directors of the company. The transaction is still subject to the company's general meeting of shareholders, Shanghai Stock Exchange and China Securities Regulatory Commission.
お知らせ • Dec 15Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces an Equity Buyback for CNY 200 million worth of its shares.Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 140 per share. The shares purchased will be used for the company's equity incentive plans and/or employee stock ownership plans. The program will be funded out of the company's own funds. The program will be valid till 12 months.
Valuation Update With 7 Day Price Move • Dec 13Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥83.82, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 185% over the past three years.
Price Target Changed • Nov 16Price target decreased to CN¥137Down from CN¥155, the current price target is an average from 2 analysts. New target price is 39% above last closing price of CN¥98.65. Stock is down 36% over the past year. The company is forecast to post earnings per share of CN¥2.19 for next year compared to CN¥1.28 last year.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Xinxin Wang was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥110, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 295% over the past three years.
Price Target Changed • Oct 28Price target decreased to CN¥137Down from CN¥155, the current price target is an average from 2 analysts. New target price is 47% above last closing price of CN¥93.30. Stock is down 42% over the past year. The company is forecast to post earnings per share of CN¥2.19 for next year compared to CN¥1.28 last year.
Reported Earnings • Oct 25Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.36 in 3Q 2021). Revenue: CN¥501.1m (up 29% from 3Q 2021). Net income: CN¥123.7m (up 49% from 3Q 2021). Profit margin: 25% (up from 21% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 21%. Earnings per share (EPS) also missed analyst estimates by 39%. Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year whereas the company’s share price has increased by 49% per year.
Major Estimate Revision • Aug 31Consensus revenue estimates fall by 14%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥2.93b to CN¥2.51b. EPS estimate fell from CN¥2.68 to CN¥2.25 per share. Net income forecast to grow 126% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target of CN¥162 unchanged from last update. Share price fell 13% to CN¥121 over the past week.
Reported Earnings • Aug 26Second quarter 2022 earnings: EPS and revenues miss analyst expectationsSecond quarter 2022 results: EPS: CN¥0.45 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥460.8m (up 52% from 2Q 2021). Net income: CN¥104.2m (up 55% from 2Q 2021). Profit margin: 23% (in line with 2Q 2021). Revenue missed analyst estimates by 4.3%. Earnings per share (EPS) also missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 85%, compared to a 42% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 30First quarter 2022 earnings: EPS misses analyst expectationsFirst quarter 2022 results: EPS: CN¥0.43 (up from CN¥0.23 in 1Q 2021). Revenue: CN¥480.5m (up 120% from 1Q 2021). Net income: CN¥100.0m (up 88% from 1Q 2021). Profit margin: 21% (down from 24% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 19%. Over the next year, revenue is forecast to grow 87%, compared to a 43% growth forecast for the industry in China.
Price Target Changed • Apr 27Price target increased to CN¥170Up from CN¥89.90, the current price target is an average from 3 analysts. New target price is 47% above last closing price of CN¥115. Stock is up 75% over the past year. The company is forecast to post earnings per share of CN¥2.66 for next year compared to CN¥1.28 last year.
Board Change • Apr 27No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Ge Yan was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 20Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥1.28 (up from CN¥0.46 in FY 2020). Revenue: CN¥1.32b (up 180% from FY 2020). Net income: CN¥295.9m (up 176% from FY 2020). Profit margin: 22% (in line with FY 2020). Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) were mostly in line with analyst estimates. Over the next year, revenue is forecast to grow 102%, compared to a 48% growth forecast for the industry in China.
Reported Earnings • Feb 28Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥1.29 (up from CN¥0.46 in FY 2020). Revenue: CN¥1.36b (up 189% from FY 2020). Net income: CN¥298.8m (up 179% from FY 2020). Profit margin: 22% (in line with FY 2020). Revenue exceeded analyst estimates by 5.5%. Earnings per share (EPS) were mostly in line with analyst estimates. Over the next year, revenue is forecast to grow 91%, compared to a 47% growth forecast for the industry in China.
Reported Earnings • Aug 26Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.078 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥304.0m (up 202% from 2Q 2020). Net income: CN¥67.2m (up 237% from 2Q 2020). Profit margin: 22% (up from 20% in 2Q 2020). The increase in margin was driven by higher revenue.
Reported Earnings • Apr 30First quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.06 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥218.6m (up 262% from 1Q 2020). Net income: CN¥53.3m (up 315% from 1Q 2020). Profit margin: 24% (up from 21% in 1Q 2020). The increase in margin was driven by higher revenue.
Reported Earnings • Apr 01Full year 2020 earnings released: EPS CN¥0.46 (vs CN¥0.58 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥471.9m (up 22% from FY 2019). Net income: CN¥107.3m (down 2.6% from FY 2019). Profit margin: 23% (down from 28% in FY 2019). The decrease in margin was driven by higher expenses.
